CGL
TMO icon

Clarius Group LLC’s Thermo Fisher Scientific TMO Stock Holding History

Clarius Group LLC’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$926K Sell
1,598
-352
-18% -$199K 0.05% 134
2025
Q3 		$946K Sell
1,950
-168
-8% -$78.2K 0.06% 135
2025
Q2 		$859K Sell
2,118
-676
-24% -$283K 0.05% 165
2025
Q1 		$1.39M Sell
2,794
-190
-6% -$103K 0.09% 104
2024
Q4 		$1.55M Buy
2,984
+176
+6% +$96.8K 0.11% 87
2024
Q3 		$1.73M Sell
2,808
-68
-2% -$40.3K 0.12% 81
2024
Q2 		$1.59M Buy
2,876
+349
+14% +$200K 0.11% 85
2024
Q1 		$1.47M Sell
2,527
-453
-15% -$254K 0.1% 90
2023
Q4 		$1.58M Sell
2,980
-759
-20% -$367K 0.13% 90
2023
Q3 		$1.89M Sell
3,739
-1,010
-21% -$538K 0.18% 65
2023
Q2 		$2.48M Sell
4,749
-141
-3% -$76.1K 0.19% 63
2023
Q1 		$2.82M Sell
4,890
-126
-3% -$71K 0.24% 52
2022
Q4 		$2.76M Sell
5,016
-105
-2% -$55.6K 0.25% 57
2022
Q3 		$2.6M Buy
5,121
+216
+4% +$121K 0.26% 52
2022
Q2 		$2.67M Sell
4,905
-722
-13% -$397K 0.27% 49
2022
Q1 		$3.75M Hold
5,627
– – 0.3% 41
2021
Q4 		$3.75M Sell
5,627
-388
-6% -$242K 0.3% 41
2021
Q3 		$3.44M Buy
6,015
+131
+2% +$71.9K 0.31% 42
2021
Q2 		$2.97M Buy
+5,884
New +$2.78M 0.27% 45
2021
Q1 		– Sell
-4,122
Closed -$1.92M – 399
2020
Q4 		$1.92M Buy
4,122
+511
+14% +$240K 0.21% 52
2020
Q3 		$1.59M Sell
3,611
-352
-9% -$145K 0.2% 56
2020
Q2 		$1.44M Buy
3,963
+746
+23% +$250K 0.2% 60
2020
Q1 		$912K Buy
3,217
+261
+9% +$82.3K 0.17% 71
2019
Q4 		$991K Sell
2,956
-6
-0.2% -$1.82K 0.16% 76
2019
Q3 		$863K Buy
2,962
+355
+14% +$102K 0.16% 81
2019
Q2 		$765K Buy
2,607
+296
+13% +$81.5K 0.15% 79
2019
Q1 		$633K Buy
+2,311
New +$575K 0.15% 82

Other funds holding TMO

JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Clarius Group LLC's TMO Position: Q4 2025 in Review

Clarius Group LLC reduced its Thermo Fisher Scientific (TMO) stake by 18% in Q4 2025, selling an estimated $199K and leaving 1,598 shares worth $926K. The position accounts for 0.05% of the portfolio, ranked #134.

Clarius Group LLC first reported a position in TMO in Q1 2019 and has held it in 27 quarters since. The position peaked at $3.75M in Q1 2022. 2,700 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Clarius Group LLC held 1,598 shares of Thermo Fisher Scientific worth $926K as of Q4 2025.
  • Clarius Group LLC sold 352 Thermo Fisher Scientific shares in Q4 2025, an estimated $199K.
  • Thermo Fisher Scientific made up 0.05% of Clarius Group LLC's portfolio in Q4 2025, its #134 holding.
  • Clarius Group LLC first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 27 quarters since.
  • Clarius Group LLC's Thermo Fisher Scientific position peaked at $3.75M in Q1 2022.
  • 2,700 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Clarius Group LLC's 13F filing for Q4 2025, filed 14 Jan 2026.